“…Twenty-one studies were conducted in clinical samples [four in First Episode of Psychosis (FEP) or early psychosis patients (Evans, Reid, Preston, Palmier-Claus, & Sellwood, 2015;Morgan et al, 2014;Peach, Alvarez-Jimenez, Cropper, Sun, & Bendall, 2019;Sun et al, 2018), three in Ultra High Risk (UHR) patients (Appiah-Kusi et al, 2017;McDonnell, Stahl, Day, McGuire, & Valmaggia, 2018;Thompson et al, 2016), 14 in non-FEP patients (Cancel et al, 2015;Chatziioannidis et al, 2019;Choi et al, 2015;Hardy et al, 2016;Isvoranu et al, 2017;Perona-Garcelán et al, 2012;Quidé, O'Reilly, Watkeys, Carr, & Green, 2018;Schalinski et al, 2019;Steenkamp, Weijers, Gerrmann Perona-Garcelán et al, 2014;Pinto-Gouveia, Matos, Castilho, & Xavier, 2014;Rössler, Ajdacic-Gross, Rodgers, Haker, & Müller, 2016;Sheinbaum, Kwapil, & Barrantes-Vidal, 2014;Shevlin, McElroy, & Murphy, 2015;Sitko, Bentall, Shevlin, O'Sullivan, & Sellwood, 2014;van Nierop et al, 2014;Wolke, Lereya, Fisher, Lewis, & Zammit, 2014;Yamasaki et al, 2016)]. Our review included 82 352 subjects from the GP and 3189 subjects from clinical studies.…”